Skin Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Skin Cancer, including details on identification, causes, prevention, treatment.

Volume 6 (2009), Issue 1 (January)

1. Paracrine signaling by platelet-derived growth factor-CC promotes tumor growth by recruitment of cancer-associated fibroblasts.
   Cancer Res, 69(1): 369-78. [Abstract] [Full-text]
2. Inducible cutaneous inflammation reveals a protumorigenic role for keratinocyte CXCR2 in skin carcinogenesis.
   Cancer Res, 69(1): 319-28. [Abstract] [Full-text]
3. Oncoprotein BMI-1 induces the malignant transformation of HaCaT cells.
   J Cell Biochem, 106(1): 16-24. [Abstract] [Full-text]
4. The role of observation in the management of atypical nevi.
   South Med J, 102(1): 45-8. [Abstract] [Full-text]
5. Treatment of angiokeratoma of Fordyce with long-pulse neodymium-doped yttrium aluminium garnet laser.
   Dermatol Surg, 35(1): 92-7. [Abstract] [Full-text]
6. Test characteristics of high-resolution ultrasound in the preoperative assessment of margins of basal cell and squamous cell carcinoma in patients undergoing Mohs micrographic surgery.
   Dermatol Surg, 35(1): 9-15; discussion 15-6. [Abstract] [Full-text]
7. Nonmelanoma skin cancers of the ear: correlation between subanatomic location and post-Mohs micrographic surgery defect size.
   Dermatol Surg, 35(1): 30-3. [Abstract] [Full-text]
8. Comparison of Mohs micrographic surgery and wide excision for extramammary Paget's Disease: Korean experience.
   Dermatol Surg, 35(1): 34-40. [Abstract] [Full-text]
9. Second primary cancers in patients with skin cancer: a population-based study in Northern Ireland.
   Br J Cancer, 100(1): 174-7. [Abstract] [Full-text]
10. Recognition of skin malignancy by general practitioners: observational study using data from a population-based randomised controlled trial.
    Br J Cancer, 100(1): 24-7. [Abstract] [Full-text]
11. Use of oral glucocorticoids and risk of skin cancer and non-Hodgkin's lymphoma: a population-based case-control study.
    Br J Cancer, 100(1): 200-5. [Abstract] [Full-text]
12. TIMP-1-GPI in combination with hyperthermic treatment of melanoma increases sensitivity to FAS-mediated apoptosis.
    Cancer Immunol Immunother, 58(3): 361-71. [Abstract] [Full-text]
13. Primary cutaneous T-cell lymphoma of unspecified type with cytotoxic phenotype: clinicopathological analysis of 27 patients.
    Cancer Sci, 100(1): 33-41. [Abstract] [Full-text]
14. Merkel cell carcinoma expresses K homology domain-containing protein overexpressed in cancer similar to other high-grade neuroendocrine carcinomas.
    Hum Pathol, 40(2): 238-43. [Abstract] [Full-text]
15. Lesion border detection in dermoscopy images.
    Comput Med Imaging Graph, 33(2): 148-53. [Abstract] [Full-text]
16. Merkel cell carcinoma.
    Cell Mol Life Sci, 66(1): 1-8. [Abstract] [Full-text]
17. Macrophage inhibitory cytokine-1: a new player in melanoma development.
    J Invest Dermatol, 129(2): 262-4. [Abstract] [Full-text]
18. Moisturizers, vehicle effects, and photocarcinogenesis.
    J Invest Dermatol, 129(2): 261-2. [Abstract] [Full-text]
19. Macrophage inhibitory cytokine-1 is overexpressed in malignant melanoma and is associated with tumorigenicity.
    J Invest Dermatol, 129(2): 383-91. [Abstract] [Full-text]
20. NKG2D ligands expression and NKG2D-mediated NK activity in Sezary patients.
    J Invest Dermatol, 129(2): 359-64. [Abstract] [Full-text]
21. Primary cutaneous marginal zone B-cell lymphomas are targeted by aberrant somatic hypermutation.
    J Invest Dermatol, 129(2): 476-9. [Abstract] [Full-text]
22. Tumorigenic effect of some commonly used moisturizing creams when applied topically to UVB-pretreated high-risk mice.
    J Invest Dermatol, 129(2): 468-75. [Abstract] [Full-text]
23. Active N-Ras and B-Raf inhibit anoikis by downregulating Bim expression in melanocytic cells.
    J Invest Dermatol, 129(2): 432-7. [Abstract] [Full-text]
24. Incidence of basal cell carcinoma multiplicity and detailed anatomic distribution: longitudinal study of an Australian population.
    J Invest Dermatol, 129(2): 323-8. [Abstract] [Full-text]
25. A prospective study of telomere length and the risk of skin cancer.
    J Invest Dermatol, 129(2): 415-21. [Abstract] [Full-text]
26. Proliferation arrest in B-Raf mutant melanoma cell lines upon MAPK pathway activation.
    J Invest Dermatol, 129(2): 406-14. [Abstract] [Full-text]
27. A new indication of botulinum toxin: leiomyoma-related pain.
    J Am Acad Dermatol, 60(2): 325-8. [Abstract] [Full-text]
28. Spitz nevi: In vivo confocal microscopic features, dermatoscopic aspects, histopathologic correlates, and diagnostic significance.
    J Am Acad Dermatol, 60(2): 236-47. [Abstract] [Full-text]
29. Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006.
    J Am Acad Dermatol, 60(2): 203-11. [Abstract] [Full-text]
30. Poor prognosis in non-Caucasian patients with early-onset mycosis fungoides.
    J Am Acad Dermatol, 60(2): 231-5. [Abstract] [Full-text]
31. Aggressive digital papillary adenocarcinoma: a report of two diseases and review of the literature.
    J Am Acad Dermatol, 60(2): 331-9. [Abstract] [Full-text]
32. Aryl hydrocarbon receptor polymorphism modulates DMBA-induced inflammation and carcinogenesis in phenotypically selected mice.
    Int J Cancer, 124(6): 1478-82. [Abstract] [Full-text]
33. Relation between animal-type melanoma and reduced nuclear expression of glutathione S-transferase pi.
    Arch Dermatol, 145(1): 55-62. [Abstract] [Full-text]
34. Subcutaneous trigger point causing radiating postsurgical pain.
    Arch Dermatol, 145(1): 52-4. [Abstract] [Full-text]
35. Estrogen receptor expression in cutaneous melanoma: a real-time reverse transcriptase-polymerase chain reaction and immunohistochemical study.
    Arch Dermatol, 145(1): 30-6. [Abstract] [Full-text]
36. Topical tretinoin therapy and all-cause mortality.
    Arch Dermatol, 145(1): 18-24. [Abstract] [Full-text]
37. Fetal microchimeric cells participate in tumour angiogenesis in melanomas occurring during pregnancy.
    Am J Pathol, 174(2): 630-7. [Abstract] [Full-text]
38. The chemokine receptor CXCR4 and the metalloproteinase MT1-MMP are mutually required during melanoma metastasis to lungs.
    Am J Pathol, 174(2): 602-12. [Abstract] [Full-text]
39. Bone marrow-derived cells are not the origin of the cancer stem cells in ultraviolet-induced skin cancer.
    Am J Pathol, 174(2): 595-601. [Abstract] [Full-text]
40. Cutaneous melanoma in Asian-Americans.
    J Surg Oncol, 99(2): 114-8. [Abstract] [Full-text]
41. A functional SNP in the MDM2 promoter, pigmentary phenotypes, and risk of skin cancer.
    Cancer Causes Control, 20(2): 171-9. [Abstract] [Full-text]
42. Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model.
    Proc Natl Acad Sci U S A, 106(4): 1193-8. [Abstract] [Full-text]
43. MicroRNA-dependent regulation of cKit in cutaneous melanoma.
    Biochem Biophys Res Commun, 379(3): 790-4. [Abstract] [Full-text]
44. Promotion of mouse two-stage skin carcinogenesis by diacylglycerol-rich edible oil.
    Cancer Lett, 275(1): 150-7. [Abstract] [Full-text]

© 2004-2010 Skin Cancer Research Today. All Rights Reserved.